Barry D. Quart

2019

In 2019, Barry D. Quart earned a total compensation of $5.9M as President and Chief Executive Officer at Heron Therapeutics, a 2% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$306,715
Option Awards$4,916,373
Salary$638,991
Other$8,400
Total$5,870,479

Quart received $4.9M in option awards, accounting for 84% of the total pay in 2019.

Quart also received $306.7K in non-equity incentive plan, $639K in salary and $8.4K in other compensation.

Rankings

In 2019, Barry D. Quart's compensation ranked 1,769th out of 13,971 executives tracked by ExecPay. In other words, Quart earned more than 87.3% of executives.

ClassificationRankingPercentile
All
1,769
out of 13,971
87th
Division
Manufacturing
628
out of 5,701
89th
Major group
Chemicals And Allied Products
188
out of 2,200
92nd
Industry group
Drugs
151
out of 1,886
92nd
Industry
Pharmaceutical Preparations
113
out of 1,398
92nd

Pay ratio

Barry D. Quart's Pay$5,870,479
Median Employee's Pay$408,623
Pay Ratio

14

to 1

In 2019, the annual total compensation of Barry D. Quart was $5,870,479.

The annual total compensation of the median employee at Heron Therapeutics was $408,623.

The ratio of Barry D. Quart's pay to the pay of median employee was therefore 14 to one.

Source: SEC filing on April 23, 2020.

Quart's colleagues

We found four more compensation records of executives who worked with Barry D. Quart at Heron Therapeutics in 2019.

2019

John Poyhonen

Heron Therapeutics

Executive Vice President, Chief Commercial Officer

2019

Kimberly Manhard

Heron Therapeutics

Executive Vice President, Drug Development

2019

Robert Hoffman

Heron Therapeutics

Chief Financial Officer

2019

Robert Rosen

Heron Therapeutics

Former President

News

In-depth

You may also like